Investments
5About BioPacific Investors
BioPacific Investors is a new angel investment group created to leverage cross-border opportunities in early-stage life science and healthcare. Will focus on US-based life science and healthcare companies with China/Asia as a key component of their business strategy. Seed or Series A funding of $250K to $1M. Access to government and VC follow-on funding in China. No fee to apply or present, but subject to screening process approval.
Want to inform investors similar to BioPacific Investors about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
BioPacific Investors Investments
5 Investments
BioPacific Investors has made 5 investments. Their latest investment was in Qool Therapeutics as part of their Series A on February 2, 2017.
BioPacific Investors Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
2/23/2017 | Series A | Qool Therapeutics | $8M | Yes | 2 | |
7/25/2012 | Series B - II | |||||
4/18/2011 | Series B | |||||
Other Investors | ||||||
Other Investors |
Date | 2/23/2017 | 7/25/2012 | 4/18/2011 | ||
|---|---|---|---|---|---|
Round | Series A | Series B - II | Series B | Other Investors | Other Investors |
Company | Qool Therapeutics | ||||
Amount | $8M | ||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 2 |
BioPacific Investors Acquisitions
1 Acquisition
BioPacific Investors acquired 1 company. Their latest acquisition was Horizon Sciences on March 17, 2009.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
3/17/2009 | Acq - Fin | 2 |
Date | 3/17/2009 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acq - Fin |
Sources | 2 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.